Skip to main content

Table 4 Adjusted association between fasting blood glucose and HbA1c in those with confirmed type 2 diabetes

From: The agreement between fasting glucose and markers of chronic glycaemic exposure in individuals with and without chronic kidney disease: a cross-sectional study

 

MODEL 1

MODEL 2

MODEL 3

β

95% CI

p

β

95% CI

p

β

95% CI

p

HbA1c

1.55

1.40 to 1.70

< 0.0001

1.56

1.41 to 1.71

< 0.0001

1.55

1.40 to 1.70

< 0.0001

Age

− 0.04

−0.07 to − 0.01

0.018

− 0.04

−0.07 to − 0.01

0.014

−0.04

− 0.07 to − 0.01

0.018

Gender

− 0.06

−0.96 to 0.84

0.898

−0.02

− 0.90 to 0.93

0.971

− 0.11

− 1.07 to 0.96

0.830

CKD

−3.00

−7.02 to 1.01

0.142

−2.91

−6.93 to 1.10

0.154

−2.98

−7.00 to 1.04

0.145

CKDxHbA1c

0.47

−0.01 to 0.96

0.054

0.47

−0.01 to 0.95

0.056

0.48

−0.00 to 0.96

0.050

BMI

0.01

−0.04 to 0.06

0.595

Haemoglobin

0.04

−0.19 to 0.28

0.718

Adjusted R2

0.66

0.66

0.66

  1. Data represents β-coefficients, 95% confidence interval, p-value and adjusted-R2. HbA1c, glycated haemoglobin; BMI, body mass index; CKD, chronic kidney disease; CKDxHbA1c, interaction between CKD and HbA1c. Model 1: HbA1c + age + gender + CKD + CKDxHbA1c; Model 2: Model 1 + BMI. Model 3: Model 1 + haemoglobin